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One  of the  characteristics  of the  membrane  attack  complex  (MAC) 1 is  that  it 
contains multiple C9 molecules in comparison with its other molecular constituents 
C5b, C6, C7, and C8  (1-4). Recently, isolated C9 was found to polymerize sponta- 
neously and form tubular structures in a time- and temperature-dependent reaction 
(5).  Polymerized C9  (poly C9)  consists of 12-16 C9 molecules and has a  molecular 
weight of-1,100,000  (6). The tubules are  16 nm long and have an inner and outer 
diameter of 10 and  21  nm, respectively. The ultrastructural appearance of poly C9 
resembles  closely that  of the  isolated  MAC  (5,  7,  8).  During  polymerization, C9 
acquires the ability to become inserted into phospholipid bilayers, render lipid vesicles 
leaky, fuse such  vesicles, or disassemble  their membranefl Despite these properties, 
poly C9 by itself could not be shown to be cytolytic for nucleated cells or erythrocytes 
from a variety of species. 
Because  of the  C9  multiplicity  within  the  MAC  and  the  ultrastructural  and 
functional  properties  of poly  C9,  the  possibility  arose  that  poly  C9  is  a  regular 
constituent of the fully assembled MAC, and, in fact, constitutes its putative hydro- 
philic  transmembrane  channel  (9,  10).  This  paper  indicates  that  MAC  assembly 
includes  the  process  of poly  C9  formation  and  that  the  typical  ultrastructural 
membrane  lesions  caused  by  complement  are  the  images  of poly  C9  formed  by 
membrane-bound C5b-8. Part of this work has been presented in an abstract  (11). 
Materials and Methods 
Complement Proteins.  C5b-6, C6, C7, and C8 were purified as described  elsewhere  (12-14). 
C5  and C9 were  purified by DEAE-Sephacel  chromatography according to the method of 
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Hammer et al. (15). The final step for C5 purification was chromatography on concanavalin  A- 
Sepharose CL4B to remove traces of contaminating IgG. The post DEAE-Sephacel C9 pool 
was further purified to homogeneity by hydroxyapatite chromatography as described (16). The 
C8  and  C9  concentration was  determined by *he  absorbance at  280  nm  using extinction 
coefficients  of e -- 1.6 and E -- 0.96 ml mg  -a cm  -1, respectively (5). Poly C9 was prepared by 
incubating  purified C9 at 1 mg/ml for 64 h at 37°C in Tris- (10 mM) buffered saline (0.15 M), 
pH  7.4, containing 25 /~g soybean trypsin inhibitor. Poly C9 was  devoid of monomeric C9 
(4.5S) as determined in the analytical ultracentrifuge. 
Radiolabeling of C5, C7, C8,  and C9 was carried out with the iodogen procedure (17) to 
reach specific radioactivities of 5 ×  105 cpm//lg protein. Functional activities of labeled proteins 
were tested by their incorporation into the SC5b-9 complex as determined by sucrose  density 
gradient ultracentrifugation. C9 was tested as follows: 0.1 ml of whole human serum containing 
10 mM EDTA was  supplemented with  105 cpm  Ie5I-C9 and with  10 #g C7  and  15/lg C8. 
SC5b-9 formation was then initiated by the addition of 30/~g C5b-6 and incubation for 30 min 
at 37 °. Controls were incubated without C5b-6. Samples were then applied to  10-40% linear 
sucrose  density gradients dissolved  in veronal-buffered saline, pH  7.4, containing 10  mM 
EDTA,  and  centrifuged  for  16  h  at  36,000  rpm  at  4°C  in  a  SW  50.1 rotor  (Beckman 
Instruments, Inc., Fullerton, CA.). After fractionation, the amount of 125I-C9 sedimenting with 
23S (18) was determined. The other proteins were examined similarly. The binding activity of 
the labeled proteins ranged from 50 to 80%. 
The binding activity of unlabeled proteins was determined by two-dimensional immunoe- 
lectrophoresis as described here for C9: immunochemically  C9-depleted serum was reconstituted 
with 50/~g/ml purified C9, and purified C7 and C8 were added to a final concentration of 100 
/Lg/ml. C5b-6 was added at concentrations ranging from 0 to 250/~g/ml and the mixture was 
incubated for 30 min at 37°C. 7-/~1 aliquots were then subjected to two-dimensional immunoe- 
lectrophoresis using anti-C9 in the second dimension. The disappearance of the C9 peak on 
addition of increasing amounts of C5b-6 indicated the formation of the SC5b-9 complex, which 
has  a  lower  electrophoretic  mobility and  did  not  react  with  the  antiserum  under  these 
conditions. All of the  C9  antigen was  bound to  SC5b-9 when C5b-6 was  at  one-half the 
molarity of the C9. Thus, 100% of the purified C9 antigen and 100% of C8 antigen, measured 
similarly, was active. Comparison of protein determinations with determinations of antigen by 
the Mancini technique indicated that essentially all the protein represented immunochemically 
reactive C8 and C9. 
Determination ofC9/C8 Molar Ratio and Preparation of Membranes  for Electron Microscopy.  The C8- 
and  C9-binding assays  are  based  on  the  virtually irreversible binding of C8  and  C9  to 
membranes bearing C5b-7 (4). When constant trace amounts of radiolabeled C8 and C9 and 
various  amounts  of  unlabeled C8  and  C9  participate  in  MAC  assembly on  erythrocyte 
membranes, competition for binding sites between labeled and unlabeled components occurs 
only when the total C8 or C9 exceeds  all available binding sites. Thus, by determining the 
minimum amount of unlabeled protein that  detectably decreases  uptake or radiolabel, the 
number of bindings sites can be calculated (Fig.  1). This assay is not influenced by possible 
inactivation of proteins during the radiolabeling procedure. 
Normal human serum was depleted of C8 and C9 by immune adsorption with the aid of 
antibodies coupled  to  Sepharose  CL4B  (13). Depletion  was  assessed  by  two-dimensional 
immunoelectrophoresis and hemolytic titration of C8 and C9.  15,000 cpm xalI-C8 was added to 
150-/~1 serum aliquots for C8 uptake studies. Each aliquot then received various amounts (0-4 
/lg) of unlabeled C8 (see Fig.  1) and 50/~1 of rabbit erythrocytes adjusted to a 25% hematocrit 
(~2.5 ×  109 cells/ml). The mixtures were incubated for 1 h at 37°C in a total vol of 250/~1. 125 
/zl of each incubation mixture was applied to a microfuge tube containing 250/zl of 10% sucrose 
dissolved  in  veronal-buffered saline,  pH  7.4, containing 0.5  mg/ml  ovalbumin,  10  mM 
benzamidine hydrochloride, and centrifuged for 5 min (model B microfuge; Beckman Instru- 
ments, Inc.). Under these conditions, both unlysed cells and cell membranes were pelleted. The 
tip  of the  microfuge  tube  containing the  pellet  was  cut  off with  a  razor  blade  and  the 
radioactivity in pellet and supernate was measured. The remainder of the incubation mixture 
not used for determination of C8 uptake was used for electron microscopy. After addition of 0.5 
ml 0.5  mM  phosphate  buffer, pH  8.0,  the  membranes were  sedimented in the  microfuge, 270  INDUCTION OF CIRCULAR C9  POLYMERIZATION BY C5b-8 
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F1o.  I.  Molar ratio of C8 and C9 bound to rabbit erythrocytes as a result of MAC-assembly. To 
obtain the C8-binding curve, 1.25 X l0  s rabbit erythrocytes were incubated with 150/~1 of C8- and 
C9-depleted human serum reconstituted with a trace of xn~I-C8 and various amounts of unlabeled 
C8. After 1 h at 37°C, specific uptake of radiolabeled C8 was measured and plotted as a function 
of input  of total C8  (A). Controls were incubated  in  the presence of EDTA and  showed <1% 
unspecific C8 binding. The inflection point of the binding curve corresponds  to the number of CS- 
binding sites (0.8/~g =  3.2 ×  10  TM molecules). C9 binding was determined in an analogous fashion 
(lower panel).  The weight ratio of 2.7 ~g C9 per/~g C8 corresponds  to a molar C9/C8 ratio of 6.7. 
washed twice with the phosphate buffer, and resuspended in 200 #1 veronal- (3.3 mM) buffered 
saline (0.15 M), pH 7.4.  Trypsin and chymotrypsin were added to a  final concentration of 100 
/~g/ml and the same incubated overnight at room temperature. After two washes with veronal- 
buffered saline and resuspension  in 50 ~1, the samples were mounted on electron microscopy 
grids, stained with 2% uranyl formate, and examined in a  Hitachi  12A (Hitachi Tokyo Ltd.), 
electron microscope. 
C9 uptake was measured similarly by the addition of 15,000 cpm 125I-C9 to serum aliquots 
reconstituted with defined amounts of unlabeled C8 and laii-C8. Unlabeled C9 (0-10/~g) was 
then added and the aliquots incubated with rabbit erythrocytes as described above. Uptake of 
a25I-C9 in dependence of the amount of unlabeled C9 was determined as outlined above for C8. 
In experiments measuring C9 binding at 4°C, lalI-C5b-8 was first formed on rabbit erythrocytes 
at  37°C for  1 h.  125I-C9 and  unlabeled  C9 were then added  to chilled aliquots and  parallel 
samples incubated at 37°C and on ice. 
C9-binding Sites on C8 in Solution.  C9-binding sites on C8 were determined  in the analytical 
ultracentrifuge by mixing purified C8 and C9 at various molar ratios in 50 mM NaC1,  10 mM 
Tris  HC1,  pH  7.4,  and  centrifugation  at  52,640  rev/min  in  an  ANF  60  rotor  (Beckman 
Instruments,  Inc.). The protein  concentrations of C8 and  C9 used are listed in Table I. The 
molar ratio of the 10.5S C8-C9 complex formed was determined from its absorbance of light at 
280 nm and from the amount of remaining free C9 (4.5S). 
Analysis of MAC-associated Poly C9 by Sodium Dodecyl Sulfate  (SDS)-Polyac~ylamide Gradient Slab 
Gel Electrophoresis.  MAC-containing  125I-C9 and  ~3aI-C7 was  formed  on  and  extracted  from 
rabbit erythroeytes as described (8).  The desoxycholate (DOC) extract was further purified by 
chromatography over Sepharose CL4B in the presence of DOC (8). For SDS gel electrophoresis, 
MAC-containing fractions were made  10%  (wt/vol)  in SDS and,  under  reducing conditions, 
2% in mercaptoethanol. After boiling for 2-5 min, samples were applied to SDS-polyacrylamide 
gradient slab gels and electrophoresis conducted using the discontinuous buffer system described 
by Laemmli (19).  The 6-era-long gradient ranged from 2.5-10% polyacrylamide overlayered by E.  R.  PODACK, J.  TSCHOPP,  AND  H.  J.  MOLLER-EBERHARD  271 
TABLE  I 
Reversible Interaction of C8 and C9 in Solution Analyzed by Analytical Ultracentrifugation 
Input 
C8  C9  C8:C9 
Sedimentation  (28 free*  (29 free*  coefficients 
C8:C9 in 
10.5S eom- 
plex:~ 
i.tg/ml  #g/ml  rnol/raol  S  #g/rM  #g/ml  raol/mol 
0  150  0:1  4.5  NA§  150  NA 
300  0  1:0  8.1  300  NA  NA 
300  150  1:1  10.5  0  0  1 
300  225  1  : 1.5  10.5, 4.5  0  75  1 
300  300  1:2  10.5, 4.5  0  150  1 
300  450  1:3  10.5, 4.5  0  300  1 
* Protein concentration determined from the absorbance of light at 280 mm of the 8.1S or 4.5S boundary, 
respectively. 
Molar ratio determined from the observed sedimentation rate of 10.5  rs corresponding to a  1:1  C8:C9 
complex and from the absorbance of light at 280 nm. 
§ Not applicable. 
2 cm 2.5% polyacrylamide and the stacking gel that was also formed by 2.5% polyacrylamide. 
The samples were subjected to electrophoresis for 16 h at 25 V, constant voltage, stained  with 
Coomassie blue and, where indicated,  sliced into 2-ram segments for determination of radio- 
activity.  Densitometric  scanning of stained  bands  was carried  out  in  a  soft  laser  scanning 
densitometer  (Biomed Instruments,  Inc., Chicago, IL). 
Immunochemical Analysis.  Antisera  to poly C9 were raised  in rabbits  by eight  injections  of 
poly C9. Double-diffusion analysis was performed  in  1% agarose containing 1% Triton-X 100. 
Results 
Formation of a Reversible Equimolar C8-C9  Complex in +olution.  The number of C9- 
binding sites  on a  molecule of C8 was determined by analytical uhracentrifugation. 
The results are listed in Table I. Whereas C8 has a  sedimentation coefficient of 8.1S 
(14) and C9 of 4.5S (20),  an equimolar mixture of C8 and C9 sedimented as a  single 
10.5S component, indicating the formation of a stoichiometric C8-C9 complex. When 
the molar concentration of C9 was raised  above that of C8, a  4.5S component was 
observed in addition to the  10.5S component. The results indicate that C8 possesses 
a single binding site of C9. 
Binding of Multiple C9 Molecules to Membrane-bound C5b-8.  To determine the molar 
ratio of C8 and C9 bound to membranes upon MAC formation, a sensitive assay was 
used that takes advantage of the high affinity of C9 (Ka a.  1011 M -1) (4) for membrane- 
bound C5b-8, as described in Materials and Methods. Briefly, normal human serum 
was  immunochemically depleted  of C8  and  C9  and  then  reconstituted  with  trace 
amounts of 131I-C8 and 125I-C9 and with various amounts of unlabeled  C8 and C9. 
After  incubation  of serum  samples  with  rabbit  erythrocytes for  1 h  at  37°C,  the 
amount of membrane-bound radioactivity was determined  and related  to input  of 
unlabeled C8 or C9 (Fig.  1). The maximum amount of unlabeled protein that did not 
cause a reduction of binding of radioactivity to the cells was considered equivalent to 
the number of available binding sites  for that protein. In the case of C8, this amount 
was 0.8/tg (Fig.  1 A) and for C9 it was 2.7 ~g (lower panel). 3 These values correspond 
s It is important that C8 and C9 are present simultaneously during MAC assembly on rabbit erythrocyte 
membranes. If C5b-8 is first formed for I h  at 37°C and C9 uptake measured in a  subsequent incubation 
for  1 h  at 37°C, the molar C9/C8 ratio drops to 3.8 and the membrane lesions have an irregular, fused 
appearance. Presumably, C5bo8 complexes cluster and thereby restrict subsequent C9 binding. 272  INDUCTION  OF CIRCULAR  C9 POLYMERIZATION  BY C5b-8 
TABLE II 
Dependence of the Molar C9/C8 Ratio of EC5b-9 on the Number of C8 Molecules Per Cell 
Number 
C5b-7 corn-  C8 molecules/  of deter- 
plexes/cell  cell  C9 molecules/cell  C9:C8 ratio*  mina  k 
tions 
2.5 X  10  4  2.5 ×  10"  16.6 ×  i0  4  6.6 (5.2-7.8)  6 
2.5 ×  10  4  6.4 ×  10  a  5.6 ×  10  4  8.8  (7.3-11.4)  3 
2.5 X  10  4  3.2 X  10  ~  3.7 ×  10  4  11.6 (10.4-12.4)  3 
2,5 ×  103  2.5 ×  103  4.4 ×  104  15.4 (12.2-21.8)  4 
* Mean value; observed range shown in parentheses. 
tO 2.56 X  104 C8 molecules and 1.72 ×  l0  s C9 molecules per ceil or 6.75 molecules C9 
per C8 molecule. This complex was assigned the formula (C5b-8)2polyC9 consistent 
with the dimer hypothesis of MAC structure. At 0°C, the binding of C9 to EC5b-8 
was reversible and the association constant derived from the midpoint of the binding 
curve was determined to be ~3 ×  107 M -1 (data not shown). 
Considering the  possibility that  singly spaced  C5b-8  complexes--as opposed  to 
clusters of such complexes--on the surface of a  cell may differ in their C9-binding 
capacity, the  following experiment was  performed.  Rabbit erythrocytes containing 
25,000 C5b-7 and 3,200-25,000 C8 molecules per cell were exposed to an excess of C9, 
and C9 uptake was then measured. The results are recorded in Table II. At 25,000 C8 
molecules per cell, an average of 6.6 C9 molecules were bound per C8 molecule. At 
3,200  C8  molecules per  cell,  an  average of  11.6  C9  molecules were  bound per  C8 
molecule.  When  2,500  C8  molecules  were  bound  to  an  equal  number  of  C5b-7 
molecules, C9 binding averaged 15.4 molecules per C8 molecule. These results suggest 
that separately spaced single C5b-8 can mediate poly C9 formation. Such complexes 
were assigned the structural formula (C5b-8)polyC9. 
Dependence  of the Ultrastructural Appearance of Membrane-bound C5b-9 on the C9 Content  of 
the Complex.  Membranes of rabbit erythroeytes bearing 25,000 C5b-8 complexes and 
various numbers of C9  molecules were  examined by  electron  microscopy  (Fig.  2). 
Membranes bearing C5b-8  but  no  C9  exhibited  a  large  number of half-ring-like 
structures (Fig. 2 A). These structures appeared to become aggregated on membranes 
with  C5b-9  complexes  that  contained one  molecule of C9,  suggesting that  C5b-8 
complexes may have become cross-linked by C9-C9 interaction at low C9 dose  (Fig. 
2 B). At a molar ratio of three C9 per C8, a small number of ring structures are visible 
(Fig.  2 C).  When six C9  molecules were  bound per  C8  molecule, the  characteristic 
complement-dependent membrane lesion or MAC image became apparent (Fig. 2 D). 
FIG.  2.  Ultrastructural comparison of membrane bound C5b-8 and C5b-9 of varying C9/C8 molar 
ratios. Erythrocyte membrane-C5b-8 or  C5b-9 complexes of  defined C9/C8  molar  ratios (as 
determined in Fig. 1) were washed with 5 mM phosphate buffer, pit 8.0, and treated with trypsin 
and chymotrypsin (100 ~g/m[) overnight at ro()m temperature. After further washing, the mem- 
branes were mounted  on  grids, stained with 2'7, uranyl  formate, and  imaged in the  electron 
microscope. (A) Membrane-bound C5b-8 imaged as clustered half-ring-like  structures (arrows). The 
erythrocyte membranes are highly disrupted (white areas devoid of negative stain). (B) C5b-9 at 1:1 
molar C8/C9 ratio appears as large, condensed aggregates (arrows), suggesting  cross-linking  of C5b- 
8 complexes by C9 at low C9 multiplicity. No circular structures are apparent.  (C) C5b-9 at  1:3 
molar C8/C9 ratio with occasional ring structures (black arrows) and the majority of complexes 
forming continuous arrays of C5b-9 aggregates (white arrows). (D)  Typical  round  lesions are 
seen at a 1:6 molar C8/C9 ratio. Bar, 400 ,~,. E.  R.  PODACK, J.  TSCHOPP,  AND H. j.  MOLLER-EBERHARD  273 274  INDUCTION  OF  CIRCULAR C9  POLYMERIZATION  BY  C5b-8 
These structures, which have the probable composition (C5b-8)zpolyC9,  are clearly 
delineated and largely unaggregated. 
As shown above, individual singly spaced C5b-8 could mediate the binding of 12- 
15  C9  molecules.  These  cells, bearing  25,000  C5b-7,  3,200 C8,  and  38,000 C9 
molecules, displayed individual ring-like structures that were widely separated from 
each other on their surface (Fig. 3 B). The molecular composition of these structures, 
presumably, is (C5b-8)poly  C9. For comparison, cells are shown that bear the same 
number of C5b-7  complexes  with, however,  25,000 C8  molecules  and  167,000 C9 
molecules (Fig. 3 A). The inset  (Fig. 3) shows isolated poly C9 for comparison. In top 
views, poly C9 has a circular structure that is identical to that of the MAC. 
Demonstration of Poly  C9 as  a  Constituent of the  MAC.  These results  indicate that 
Fie.  3.  Comparative ultrastructural analysis of membranes containing complexes with the com- 
position  (C5b-8)zpoly C9 (A) and (C5b-8)polyC9  (B). (C5b-8)2polyC9 formed when 25,000 C5b-7 
complexes per cell bound 25,000 C8 molecules and 167,000 C9 molecules. The resulting complexes 
are imaged as typical complement lesions, many of which exhibit a fine structure of poly C9. (C5b- 
8)polyC9 formed when 25,000 C5b-7 complexes per cell bound 3,200 C8 and 38,000 C9 molecules. 
Widely spaced  typical  lesions  (B)  are  visible  (black  arrows)  in  addition  to  aggregated C5b-7 
complexes  (white arrows), which did not bind C8 or C9. (Inset) the uhrastructural image (top and 
side views) of isolated poly C9 are shown for comparison. Bar, 400 ]k. E.  R.  PODACK, J.  TSCHOPP, AND  H. J.  MULLER-EBERHARD  275 
whereas  one  molecule  of  C8  in  solution  can  bind  only  one  molecule  of  C9,  a 
membrane-bound  C8 molecule, in  the form of the C5b-8 complex, can  mediate  the 
binding of many C9 molecules. It was, therefore, examined whether C5b-8 can induce 
C9 polymerization.  Direct  evidence for the occurrence of poly C9 in  the MAC  was 
obtained by subjecting  the isolated complex containing C9 in radiolabeled  form to 
SDS-polyacrylamide gradient  slab  gel electrophoresis.  The  MAC  was isolated  from 
rabbit erythrocytes after treatment with human serum containing 125I-C9 and a31I-C7. 
Fig. 4 shows the distribution of protein and of C9 radioactivity throughout the gel. In 
addition  to monomeric C9  (Mr -  71,000)  and  dimeric  C9  (Mr =  155,000),  a  large 
proportion (43.9%)  of high molecular weight C9 is seen. The position of this material 
in  the  2.5-10%  gel  indicates  a  molecular weight of ~1,100,000,  suggesting that  the 
polymer contains  12-16 C9 monomers. Not only is this polymer resistant  to dissocia- 
tion by SDS in nonreduced form, but it is also resistant to dissociation under reducing 
conditions as shown in Fig. 5. The properties of the MAC-associated high molecular 
weight C9 are, with respect to molecular weight and resistance to SDS and reducing 
agents, characteristic of the recently described poly C9 (5), the tubular structure that 
is capable of forming channels through lipid  bilayers.  Fig. 6  shows an  SDS slab  gel 
electrophoresis  analysis  of isolated  C9  after  incubation  for  64  h  at  37°C.  During 
incubation, C9 underwent spontaneous polymerization, and ~50% ofpoly C9 became 
resistant  to  dissociation  by  SDS  and  reducing  agents  and  exhibited  an  apparent 
molecular weight of 1.1 million. 
An antiserum produced to poly C9 detects, on the polymer, antigenic determinants 
that  are not present  on monomeric C9. An Ouchterlony analysis using anti-poly C9 
shows the precipitin line of poly C9 heavily spurring over that of monomeric C9 (Fig. 
7,  center).  The  same  precipitin  pattern  is  observed  when  the  isolated  MAC  is 
FIC. 4.  Demonstration of SDS-resistant poly C9 as constituent ofthe MAC by SDS-polyacrylamide 
gradient slab gel electrophoresis. The 8-em-long gel contained  2.5-10% polyacrylamide and was 
overlayered by a 2.5% stacking gel. 50 ~g isolated MAC was applied to the slab in SDS sample 
buffer under  nonreducing  conditions and  subjected  to electrophoresis for  16  h  at  25  V.  The 
Coomassie blue-stained gel is shown together with the distribution of C9-assoeiated radiolabel (A) 
and the densitometric scan of the dye distribution  in the  gel (B). The tool wt of poly C9 was 
estimated to be 1.1 ×  l0  s by comparison with marker proteins. 276  INDUCTION  OF  CIRCULAR  C9  POLYMERIZATION  BY  C5b-8 
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FIG.  5.  Resistance of MAC-associated poly C9 to dissociation by SDS under reducing conditions. 
The MAC containing lalI-C7 and 12si-C9 was isolated as described and subjected to SDS-polyacryl- 
amide gradient gel electrophoresis as described in Fig. 4. The gel was sliced into 2-mm sections for 
radioactivity determinations. After reduction (A) poly C9, monomeric C9, and C7 migrate slightly 
slower  than  the  nonreduced  proteins.  The  C9  dimer  (mol  wt  =  155,000)  was converted  to  the 
monomer on reduction. 
Fro.  6.  Resistance of isolated poly C9 to dissociation by SDS under reducing (R) and nonreducing 
(NR)  conditions. C9 was polymerized at  1 mg/ml in Tris-buffered saline at 37 °  C  for 64 h. 20/~g 
was applied to the polyacrylamide gradient slab (2.5-10%) without (track  1) or with (track 2) prior 
reduction. Approximately 50% of the polymerized C9 was resistant to dissociation to SDS, Track 3 
represents  IgM  (mol  wt  ~  900,000)  and  track  4  marker  proteins  with  the  indicated  molecular 
weights K, 1,000  mol wt. E.  R.  PODACK, J.  TSCHOPP,  AND H. J.  MULLER-EBERHARD  277 
FIG. 7.  C9-derived neoantigens in the MAC and in poly C9. The wells contained 12 #g MAC, 7 
#g C9 or poly C9, and 15/.tl antiserum prepared by immunizing rabbits with poly C9. 1% agarose 
containing 1% Triton-X  100 was used for double diffusion at 4°C to prevent polymerization of 
monomeric C9. 
compared with monomeric C9 (Fig. 7, right). That the same neoantigens occur in the 
MAC and in poly C9 is shown by the precipitin pattern of apparent identity (Fig.  7, 
left). 
Discussion 
The results indicate  that  poly C9  may be a  regular constituent  of the  MAC  and 
that C9 polymerization is induced by membrane-bound C5b-8. The evidence for the 
occurrence of poly C9 in the MAC is the following: (a) poly C9 (Mr "" 1,100,000)  was 
clearly detectable by SDS-gel electrophoresis of MAC isolated from complement-lysed 
erythrocytes. Like poly C9 produced by prolonged incubation at 37°C  from isolated 
C9  (5), the MAC-derived poly C9 was resistant to dissociation by SDS and reducing 
agents;  (b)  the  MAC  contains  many C9  molecules;  (c)  identical  neoantigens  were 
expressed by poly C9 and the MAC;  and  (at) the ultrastructural  image of the MAC 
resembles that of poly C9 (5). Because isolated poly C9 inserts itself into lipid bilayers 
and renders liposomes leaky (21), it is probably that poly C9 provides the transmem- 
brane  protein  channel  that  has  been  postulated  to  be  an  integral  structure  of the 
MAC (9). 
Instead of all five MAC precursor proteins, as originally envisaged, only C9 forms 
the channel wall. The manner in which polymerization proceeds is largely unknown. 
The  spontaneous  polymerization  of C9  requires  a  much  greater  activation  energy 
than  that mediated by C5b-8  (5).  A  molecule of C8 in solution has one C9 binding 
site and C8-C9 association is reversible (Ka  -~  107  M-l).  However, a  cell-bound  C8 
molecule  (C5b-8)  can  mediate  the  binding  of  many  of  C9  molecules  and  that 
association is virtually irreversible (K~ ~  10  la M -x) (4).  It may be assumed, therefore, 
that  the  C9-binding  site  on  C8  within  the  C5b-8  organization  becomes  the  C9 
polymerization site. We postulate that binding of a molecule of C9 to C5b-8 facilitates 
C9-C9  interaction  and  that  the  energy  derived  from  that  interaction  effects  the 
unfolding of monomeric C9  (long axis: ~  80 A)  to the poly C9 subunit  (long axis:  ~- 
o 
160  A),  which  is  amphiphilic  and  capable  of  inserting  itself  into  hydrophobic 
environments.  No  enzymatic  function  has  been  attributed  to  C8  or  its  subunits. 
However,  C6  has  been  reported  to  contain  a  catalytic  site  that  hydrolyzes  acetyl 
glycyl-lysine methyl ester and  which  can  be inactivated by binding  of diisopropyl- 
phosphorofluoridate (22). There is some indication that C7 has similar properties (23). 
End group analysis of C9 and poly C9 is needed to ascertain whether or not proteolytic 
attack is involved in the polymerization reaction. 278  INDUCTION OF CIRCULAR C9  POLYMERIZATION BY C5b-8 
C5b-9 may vary greatly in its composition and ultrastructural appearance, depend- 
ing  on  C9  supply  and  the  cell  surface  distribution  of its  precursor,  C5b-8.  When 
individual  C5b-8  complexes are  exposed  to  an  excess  of C9,  they  bind  12-16  C9 
molecules, and by electron microscope analysis of the cell surface, individual, widely 
separated poly C9 rings are visualized. Such complexes were assigned the composition 
(C5b-8) polyC9. When clusters of C5b-8 were saturated with C9, an average of 6-8 C9 
molecules were bound per complex. A large number of typical poly C9 rings was seen 
on  those  cells  in  close  proximity.  These  complexes were  assigned  the  composition 
(C5b-8)2polyC9.  We suggest  that  in  the  former situation,  one poly C9  structure  is 
generated  by one  polymerization site  (C5b-8),  whereas  in  the  latter  situation,  one 
poly C9 is formed by two such sites or by a C5b-8 dimer. 
If the supply of C9 i~ limited and the density of membrane-bound C5b-8 is high, 
poly C9 rings may not form at all. Instead, multiple C5b-9 complexes may aggregate 
within the membrane due to C9-C9 interaction. Heavy aggregation was observed at 
molar C9/C8 ratios of 1:1  and 3:1  (Fig.  2).  Although discrete protein channels may 
not be formed under these conditions, the formation of a network of C5b-9 aggregates 
may be an efficient mechanism of labilizing a biological membrane. However, when 
cells  are  lysed  by  serum  in  vitro  and  complement  activation  via  the  classical  or 
alternative  pathway  is  pronounced,  the  prevalent  MAC  species  generated  has  the 
composition (C5b-8)2polyC9.  Because the concentration of the MAC precursor pro- 
teins in serum is relatively high, C5b-9 will be deposited on the target cell at a  high 
density and, therefore, conditions characteristic of a molar C9/C8 ratio of 6-8 pertain. 
From the foregoing analysis, it is evident  that  the molecular weight of the MAC 
may vary widely  depending  on  its subunit  composition.  The calculated  molecular 
weight of (C5b-8)polyC9 is  ~ 1.6  ×  106, that  of (C5b-8)2polyC9 is  -2.2  ×  106, and 
that of multimers of the MAC, several million. In fact, published values range from 
one million (24)  to several million (8, 25). 
The various forms of C8-C9 interaction  that occur as part of the MAC assembly 
are summarized in Table III. Reaction  1 represents the reversible association of one 
molecule of C8 and one molecule of C9 in solution; 2, the reversible association of C9 
with C5b-8 on cells at 0°C;  3, the irreversible binding of C9 to C5b-8 at 37°C with 
concomitant C9 activation  ((:19"); 4, the aggregation of C5b-9 at low C9/C8 molar 
ratio;  5,  the  formation  of poly C9  by  an  individual  C5b-8  in  C9  excess;  and  6, 
formation of poly C9 by two clustered C5b-8 (dimer). 
Previous  estimates  of the  number  of C9  molecules  in  the  C5b-9  complex  have 
TABLE III 
Various C8-C9 Interactions Occurring During MAC Formation 
(1)  C8 + C9 ~  C8,C9 
0°C 
(2)  C5b-8 + C9 ~  C5b-8,C9 
37°C 
(3)  C5b-8 + C9  ~ C5b-8,C9"$ 
37°C 
(4)  C5b-8,C9":1:  , (C5b-8,C9). 
37°C 
(5)  C5b-8,C9"$ + C9  ~ (C5b-8)polyC9§ 
37°C 
(6)  C5b-8,C9"$ + C9  , (C5b-8)2polyC9§ 
~: C9", activated C9 capable of inducing C9-C9 interaction. 
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varied between one and  six  (1-4,  26).  The original  quantitation  of maximum  C9 
binding  capacity yielded a  value  of six  per  C8  molecule  (2).  The  number  of C9 
molecules needed to produce one functional lesion was estimated to be 1-2 (26)  and 
3-6 (2).  When it became possible to examine the composition of the isolated MAC 
directly by SDS-polyacrylamide gel electrophoresis, two to three molecules of C9 were 
found per molecule of C5b, C6, C7, or C8 (3, 8, 18). Poly C9 escaped detection by this 
technique and was found only when SDS-polyacrylamide gradient slab  gel electro- 
phoresis  was  used  as  reported in  this  paper.  The  SDS-resistant  polymers  (Fig.  4) 
probably constitute complete ring structures, and  the monomeric C9 that  was also 
present  may  have  been  derived  from  incompletely polymerized,  SDS-susceptible 
oligomers. The nature of the forces that are responsible for the strong intermolecular 
interactions within poly C9 remains to be identified. 
It should be borne in mind that C5b-8 even without C9 displays a certain degree 
of membranolytic activity. The complex can lyse erythrocytes (20, 27) and kill serum- 
sensitive Neisseria gonorrhoeae (28), and individuals with homozygous C9 deficiency do 
not seem to have an increased susceptibility to bacterial infections, whereas individuals 
with other complement deficiencies do (29-33). Apparently, the phospholipid-binding 
capacity of C5b-8  (34, 35) and the ability of the complex to reorganize and thereby 
weaken membrane structure (36) are sufficient to impair the normal function of some 
biological  membranes.  On  the  other hand,  C9  appears  essential  for the  killing of 
Escherichia coli (37), Raji cells (38,  39), and, presumably, many other nucleated cells 
by complement. The role of C9 in the killing mechanism may be twofold: to enhance 
the membrane-labilizing effect of C5b-8 by forming aggregates of this complex; and 
to form transmembrane protein channels. 
Previously, the role of C9 in MAC assembly was thought to be the dimerization of 
C5b-8  (40).  Bound to a small liposome, an individual C5b-8 complex was visualized 
in an electron microscope as a  half-ring connected with the plane of the membrane 
by a stalk. On addition of C9, the stalk widened, i.e., the space between half-ring and 
membrane  appeared  to  be  spanned  by  protein.  The  typical  MAC  image,  which 
cannot be observed in  absence of C9, was  therefore interpreted as  two fused half- 
cylinders or as the dimer of C5b-9. This interpretation is essentially correct because 
the MAC may contain two C5b-8 complexes and  12-16 C9 molecules (41). However, 
because  it  is  now realized that  poly C9  alone  produces  the  ultrastructural  image 
previously thought to be characteristic of the entire MAC  (5), the question arises as 
to the location of C5b-8 within the MAC assembly. Current ultrastructural analyses 
suggest that C5b-8 is attached to the poly C9 tubule as a structure that is not readily 
detected by the negative-staining technique (J. Tschopp, H. J. Miiller-Eberhard, and 
E. R. Podack, unpublished observations). 
In conclusion, we wish to suggest that C5b-8 polymerizes C9 and that the amphi- 
philic poly C9 tubule inserts itself into the hydrocarbon core of a  target membrane. 
Thus,  we  envisage  the  function  of C9  is  to  provide the  poly C9  transmembrane 
channel of the MAC and the function of C5b-8 is to polymerize C9 and determine 
the site of  channel formation. The structure of  the MAC is best described as comprising 
a poly C9 tubule with one or two C5b-8 attachments. 
Summary 
Evidence has  been presented suggesting  that  during assembly of the  membrane 
attack complex (MAC) of complement, the C5b-8 complex induces polymerization of 280  INDUCTION OF CIRCULAR C9  POLYMERIZATION  BY C5b-8 
C9. The C9 polymer was detected by sodium dodecyl sulfate (SDS) gel electrophoresis 
of MAC  isolated  from complement-lysed erythrocytes. It  resembled  the  previously 
described  polymerized  C9  (poly  C9)  produced  from  isolated  monomeric  C9  by 
prolonged incubation  at  37°C  in  that  it  was resistant  to  dissociation  by SDS  and 
reducing agents and had an apparent molecular weight of ~ 1.1 million. The presence 
of  poly  C9  in  the  MAC  was  further  supported  by  the  expression  of  identical 
neoantigens  by the  MAC  and  poly C9  and  by the  high  C9  content  of the  MAC 
relative to its  other constituents.  Isolated C8 in solution was found to have a  single 
C9-binding site.  In mixture, the two proteins formed a reversible equimolar complex 
that had a sedimentation coefficient of 10.5S. In contrast, a single, cell-bound C5b-8 
complex was found to bind up to  12-15 C9 molecules and clusters of C5b-8 bound 
6-8 C9 molecules per C8 molecule. In either case, typical uhrastructural  membrane 
lesions  were  observed,  suggesting  that  the  membrane  lesion  is  identical  with  the 
tubular poly C9 consisting of 12-16 C9 molecules, and that the MAC can have either 
the composition (C5b-8)polyC9 or (CSb-8)2polyC9. When C9 input was restricted so 
that the molar C9/C8 ratio was --<3, C9-induced aggregates of C5b-8 were observed 
but  virtually no circular membrane lesions were  found. We suggest, therefore,  that 
C9, at low dosage, causes cross-linking of multiple C5b-8 complexes within the target 
membrane and that, at high dosage, C9 is polymerized by C5b-8 to form a transmem- 
brane channel within the MAC assembly. It is primarily the C9 polymer that evokes 
the ultrastructural image of the MAC or of membrane lesions caused by complement. 
We thank Ms. Kerry Pangburn for excellent technical assistance. 
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